Sanjay Chandragiri, MD
Psychiatry · Dunmore, PANPI 1467433060
Payments from drug & device makers
Across 977 payments — averaging $323.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$96K
- Johnson & Johnson$95K
- Alkermes, Inc.$43K
- Vanda Pharmaceuticals Inc.$29K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$12K
- plus $14K from 15 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 174 | $95,935 |
| Johnson & Johnson | 222 | $95,431 |
| Alkermes, Inc. | 71 | $43,446 |
| Vanda Pharmaceuticals Inc. | 49 | $28,739 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 70 | $25,961 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $11,850 |
| Neurocrine Biosciences, Inc. | 112 | $10,052 |
| Otsuka America Pharmaceutical, Inc. | 50 | $1,057 |
| Teva Pharmaceuticals USA, Inc. | 53 | $869 |
| Takeda Pharmaceuticals U.S.A., Inc. | 58 | $710 |
| Lundbeck LLC | 31 | $448 |
| Sunovion Pharmaceuticals Inc. | 26 | $327 |
| Axsome Therapeutics, Inc. | 20 | $310 |
| Almatica Pharma LLC | 10 | $204 |
| Neuronetics, Inc. | 5 | $143 |
| Eisai Inc. | 10 | $132 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| Supernus Pharmaceuticals, Inc. | 4 | $60 |
| Bausch Health US, LLC | 3 | $52 |
| Biogen | 1 | $15 |
| Corium, LLC | 1 | $12 |
How this compares
$315,851 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Dunmore
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.